This compound is primarily used in the field of hormone therapy and pharmaceuticals. It serves as a synthetic estrogen derivative, often employed in the development of hormone replacement therapies (HRT) for managing symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis. Additionally, it has potential applications in contraceptive formulations due to its estrogenic activity. Its cyclohexanecarboxylate moiety enhances its stability and bioavailability, making it suitable for controlled-release formulations. Research also explores its use in treating certain hormone-dependent cancers, where modulating estrogen levels can be therapeutic.